EQS-News: Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.
EQS-News: Redcare Pharmacy N.V.
/ Key word(s): Strategic Company Decision
Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.
13.06.2023 / 09:32 CET/CEST
The issuer is solely responsible for the content of this announcement.
Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leading e-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the simultaneous launch of the new corporate website, the corporate rebranding is now official.
With today’s event, Europe’s largest one-stop pharmacy takes another step in its rebranding, officially launching the new corporate brand Redcare Pharmacy N.V. The change of the ticker symbol from SAE to RDC was completed during an opening bell ceremony at the Frankfurt Stock Exchange, attended by the Executive Management Board, representatives of the Supervisory Board and other senior management members.
Redcare Pharmacy is more than an e-pharmacy, more than just a webshop. The brand itself stands for care, innovative solutions and services dedicated to the health of customers, employees and other stakeholders. The new name reflects the health care aspect as well as the internationalisation of the e-pharmacy that is currently active in seven countries. Red picks up on the pharmacy colour that is used in the main markets; Pharmacy represents the core business. The new name applies exclusively to the corporate brand. The names of the webshops, subsidiaries and other entities will stay the same.
Theresa Holler, Chief Operating Officer and responsible pharmacist, comments, “Today marks a significant milestone in our company’s history. By changing our name to Redcare Pharmacy, we want to emphasise our focus on providing comprehensive care and guidance for our customers in all aspects of their health. We are proud to be the one-stop pharmacy of the future. Actually, Redcare Pharmacy signifies the beginning of a new, exciting era for us.”
An additional milestone to further emphasise this next chapter for the company was the simultaneous launch of the new corporate website under the new name, design and logo. By presenting itself as Redcare Pharmacy, the company reflects its clear focus on people, to guide and support them on their way to better health.
The new corporate website can be found at www.redcare-pharmacy.com.
About Redcare Pharmacy
Originally founded in 2001, Redcare Pharmacy (formerly known as Shop Apotheke Europe) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.
Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven.
As the one-stop pharmacy of the future, Redcare Pharmacy offers almost 10 million active customers a wide range of more than 150,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany.
Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management.
Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. Currently part of the SDAX, as of 19 June 2023, the company will be a member of the MDAX selection index.
13.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
|
Language: |
English |
Company: |
Redcare Pharmacy N.V. |
|
Erik de Rodeweg 11-13 |
|
5975 WD Sevenum |
|
Netherlands |
Phone: |
0800 - 200 800 300 |
Fax: |
0800 - 90 70 90 20 |
E-mail: |
[email protected] |
Internet: |
www.redcare-pharmacy.com |
ISIN: |
NL0012044747, DE000A19Y072 |
WKN: |
A2AR94, A19Y072 |
Indices: |
SDAX |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: |
1655053 |
|
End of News |
EQS News Service |
1655053 13.06.2023 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Umsatzerlöse1 |
283,99 |
539,71 |
701,01 |
968,06 |
1.060,32 |
1.204,35 |
1.798,76 |
EBITDA1,2 |
-12,14 |
-15,56 |
-18,58 |
15,20 |
-38,73 |
-29,66 |
39,99 |
EBITDA-Marge3 |
-4,27 |
-2,88 |
-2,65 |
1,57 |
-3,65 |
-2,46 |
|
EBIT1,4 |
-19,20 |
-28,73 |
-33,45 |
-0,87 |
-65,70 |
-69,17 |
-17,30 |
EBIT-Marge5 |
-6,76 |
-5,32 |
-4,77 |
-0,09 |
-6,20 |
-5,74 |
-0,96 |
Jahresüberschuss1 |
-21,36 |
-33,61 |
-36,27 |
-16,77 |
-74,19 |
-77,65 |
-11,61 |
Netto-Marge6 |
-7,52 |
-6,23 |
-5,17 |
-1,73 |
-7,00 |
-6,45 |
-0,65 |
Cashflow1,7 |
-23,24 |
-23,54 |
-30,37 |
17,80 |
11,64 |
-29,11 |
61,46 |
Ergebnis je Aktie8 |
-2,25 |
-2,79 |
-2,78 |
-1,17 |
-4,15 |
-4,32 |
-0,73 |
Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Forvis Mazars
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Redcare Pharmacy |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
A2AR94 |
143,000 |
Halten |
2.908,98 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
79,44 |
0,00 |
0,00 |
-68,49 |
KBV |
KCV |
KUV |
EV/EBITDA |
5,57 |
47,33 |
1,62 |
76,84 |
Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23 in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
17.04.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
25.04.2024 |
30.07.2024 |
05.11.2024 |
05.03.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
4,19% |
8,04% |
9,16% |
17,02% |
|
|